Skip to main content

Analyzing the Aggregation Properties of Alpha-synuclein in Different Genetic Subtypes of Parkinson’s Disease

Study Rationale: Abnormal clumping of alpha-synuclein appears to be an important cause for the death of dopamine cells in Parkinson disease (PD). Recent studies discovered that small amounts of tiny alpha-synuclein aggregates exist in tissues and body fluids of people with PD, and that these “seeds” can induce the formation of further clumping of alpha-synuclein in a test tube. We have found that this seeding capacity depends on the genetic mutation underlying the disease. In this study, we will investigate the reasons for this variability in alpha-synuclein seeding behavior. 

Hypothesis: We hypothesize that differences in the chemical modifications of alpha-synuclein proteins are responsible for the differences in seeding capacity of alpha-synuclein in the cerebrospinal fluid (CSF) of individuals with different genetic forms of PD.

Study Design: We will perform seeding aggregation assays on CSF collected from people with different genetic forms of PD to characterize the seeding potential of their alpha-synuclein proteins. We will then analyze the chemical modifications of these different alpha-synuclein proteins and compare their modification patterns and quantities. Lastly, we will characterize the biophysical properties of the different alpha-synuclein forms we identify.

Impact on Diagnosis/Treatment of Parkinson’s disease: Analysis of the factors that determine the seeding and aggregation properties of the alpha-synuclein protein will help us to understand the reasons for the variability in disease progression and provide a basis for more specific treatments targeted at the different subtypes of PD.

Next Steps for Development: Next steps will be to develop tests for distinguishing the different alpha-synuclein subtypes, as well as subtype-specific treatments for diminishing alpha-synuclein aggregation.


Researchers

  • Thomas Gasser, MD, PhD

    Tuebingen Germany


  • Kathrin Brockmann, MD

    Tuebingen Germany


  • Markus Zweckstetter, PhD

    Gottingen Germany


  • Christian Johannes Gloeckner, PhD

    Tubingen Germany


Discover More Grants

Search by Related Keywords

Within the Same Funding Year

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.